GPBAR1 and lung cancer: More and more research results have revealed that TCDCA, as one of the main active ingredients of bile acids, after combining and activating TGR5 in lung cancer cells of H1299, can increase cAMP content and elevate phosphorylation levels of protein kinase A (PKA) and CREB [22].